Histones (ng/ml) | P-value | |||
Median (IQR) | Range | |||
Thrombotica | No | 2.68 (2.16–3.2) | 1.79–10.73 | 0.000** |
Yes | 7.79 (4.61–9.76) | 2.31–15.79 | ||
1ry/2ry APLSa | 1ry | 7.07 (3.2–9.66) | 1.79–15.79 | 0.42 |
2ry | 4.61 (3.46–8.7) | 2.15–12.95 | ||
Number of lab Positive Autoantibodieb | Single positivity | 2.4 (2.16–4.07) | 2.06–9.76 | 0.006** |
Double positivity | 7.16 (3.46–9.39) | 3.07–10.73 | ||
Triple positivity | 7.24 (4.12–9.66) | 1.79–15.79 | ||
MPO (ng/ml) | P-value | |||
Median (IQR) | Range | |||
Thrombotica | No | 3.73 (2.57–5.9) | 1.43–8.76 | 0.001** |
Yes | 7.62 (5.56–11.51) | 1.79–16.92 | ||
1ry/2ry APLSa | 1ry | 6.21 (4.08–10.22) | 2.04–16.92 | 0.446 |
2ry | 7.23 (5.39–11.73) | 1.43–16.54 | ||
Number of lab Positive Autoantibodiesb | Single positivity | 4.12 (3.13–7.3) | 2.04–11.51 | 0.073** |
Double positivity | 7.6 (5.56–8.02) | 1.43–9.94 | ||
Triple positivity | 7.43 (5.39–11.73) | 1.79–16.92 |